A Combined Proteomics and Metabolomics Profiling of Gastric Cardia Cancer Reveals Characteristic Dysregulations in Glucose Metabolism

Gastric cardia cancer (GCC), which occurs at the gastric-esophageal boundary, is one of the most malignant tumors. Despite its high mortality and morbidity, the molecular mechanism of initiation and progression of this disease is largely unknown. In this study, using proteomics and metabolomics appr...

Full description

Saved in:
Bibliographic Details
Published in:Molecular & cellular proteomics Vol. 9; no. 12; pp. 2617 - 2628
Main Authors: Cai, Zhen, Zhao, Jiang-Sha, Li, Jing-Jing, Peng, Dan-Ni, Wang, Xiao-Yan, Chen, Tian-Lu, Qiu, Yun-Ping, Chen, Ping-Ping, Li, Wen-Jie, Xu, Li-Yan, Li, En-Ming, Tam, Jason P.M., Qi, Robert Z., Jia, Wei, Xie, Dong
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-12-2010
The American Society for Biochemistry and Molecular Biology
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Gastric cardia cancer (GCC), which occurs at the gastric-esophageal boundary, is one of the most malignant tumors. Despite its high mortality and morbidity, the molecular mechanism of initiation and progression of this disease is largely unknown. In this study, using proteomics and metabolomics approaches, we found that the level of several enzymes and their related metabolic intermediates involved in glucose metabolism were deregulated in GCC. Among these enzymes, two subunits controlling pyruvic acid efflux, lactate dehydrogenase A (LDHA) and pyruvate dehydrogenase B (PDHB), were further analyzed in vitro. Either down-regulation of LDH subunit LDHA or overexpression of PDH subunit PDHB could force pyruvic acid into the Krebs cycle rather than the glycolysis process in AGS gastric cancer cells, which inhibited cell growth and cell migration. Our results reflect an important glucose metabolic signature, especially the dysregulation of pyruvic acid efflux in the development of GCC. Forced transition from glycolysis to the Krebs cycle had an inhibitory effect on GCC progression, providing potential therapeutic targets for this disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Both authors contributed equally to this work.
ISSN:1535-9476
1535-9484
DOI:10.1074/mcp.M110.000661